Type II hyperprolinemia:: a case report

被引:0
|
作者
Önenli-Mungan, N
Yüksel, B
Elkay, M
Topaloglu, AK
Baykal, T
Özer, G
机构
[1] Cukurova Univ, Fac Med, Dept Pediat Endocrinol & Metab, Adana, Turkey
[2] Cukurova Univ, Fac Med, Dept Pediat Neurol, Adana, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Pediat Metab & Nutr, Istanbul, Turkey
关键词
hyperprolinemia;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hyperprolinemia type II (HP II) is a rare inherited metabolic disease due to the deficiency of pyroline-5-carboxylate dehydrogenase. It is generally believed to be a benign condition although some patients have neurological problems such as refractory convulsions. Here we report a six-year-old girl with HP II who admitted to our hospital with recurrent seizure refractory to multiple antiepileptic drugs. She was the third child of healthy, consanguineous parents. The family history was negative for neurological and renal disorders. On physical examination, she had no facial dysmorphy; the anthropometric measurements, and systemic and neurological examinations were normal. Mental and motor development was appropriate for her age. Laboratory findings revealed elevated levels of proline, glycine, and ornithine in serum and pyrroline-5-carboxylate and hydroxproline in urine. Cerebral computerized tomography and magnetic resonance imaging were both normal. Electroencephalogram showed a very active epileptic abnormality; partial control of seizures was achieved by two antiepileptics. Increased plasma glycine and ornithine levels are the unique features of our case when compared to the other HP II cases reported in the literature.
引用
收藏
页码:167 / 169
页数:3
相关论文
共 50 条
  • [1] CASE SERIES OF HYPERPROLINEMIA TYPE II IN IRELAND
    Murphy, A. M.
    Deverell, D.
    Hendroff, U.
    Treacy, E.
    Mayne, P. D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S187 - S187
  • [2] Conduct disorder and hyperprolinemia type I: A case report
    Olivier, L.
    De Juan, O.
    Andreu, H.
    Bueno, L.
    Llobet, M.
    Ortiz, A.
    Morer, A.
    Lazaro, L.
    Ilzarbe, D.
    EUROPEAN PSYCHIATRY, 2023, 66 : S205 - S205
  • [3] Conduct disorder and hyperprolinemia type I: A case report
    Olivier, L.
    De Juan, O.
    Andreu, H.
    Bueno, L.
    Llobet, M.
    Ortiz, A.
    Morer, A.
    Lazaro, L.
    Ilzarbe, D.
    EUROPEAN PSYCHIATRY, 2023, 66 : S205 - S205
  • [4] HYPERPROLINEMIA TYPE-II
    APPLEGARTH, DA
    DOOLEY, KC
    AMERICAN JOURNAL OF HUMAN GENETICS, 1978, 30 (06) : A20 - A20
  • [5] HYPERPROLINEMIA TYPE-II
    APPLEGARTH, DA
    INGRAM, P
    HINGSTON, J
    HARDWICK, DF
    CLINICAL BIOCHEMISTRY, 1974, 7 (01) : 14 - 28
  • [6] HYDROXYPROLINE METABOLISM IN TYPE-II HYPERPROLINEMIA
    SIMILA, S
    ANNALS OF CLINICAL BIOCHEMISTRY, 1979, 16 (JUL) : 177 - 181
  • [7] TYPE-II HYPERPROLINEMIA WITH RENAL INVOLVEMENT
    BELLET, H
    MORIN, D
    DAUDET, H
    DUMAS, ML
    VALETTE, H
    DEBORNIER, BM
    DUMAS, R
    JOURNAL OF INHERITED METABOLIC DISEASE, 1991, 14 (05) : 846 - 847
  • [8] LONG TERM OUTCOME IN HYPERPROLINEMIA TYPE II
    van de Ven, S.
    Gardeitchik, T.
    Kouwenberg, D.
    Kluijtmans, L.
    Morava, E.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S29 - S29
  • [9] DIETARY TREATMENT IN HYPERPROLINEMIA TYPE-II
    SIMILA, S
    ACTA PAEDIATRICA SCANDINAVICA, 1974, 63 (02): : 249 - 256
  • [10] DEFECTIVE HYDROXYPROLINE METABOLISM IN TYPE-II HYPERPROLINEMIA
    GOODMAN, SI
    MACE, JW
    MILES, BS
    TENG, CC
    BROWN, SB
    BIOCHEMICAL MEDICINE, 1974, 10 (04): : 329 - 336